Aim & Scope
Kompass is aimed at clinicians and general practitioners with a focus on young, committed medical professionals. The heart of the series is the transfer of knowledge from research to practice, with which the experienced advisory board names the relevance of research findings for practical work with patients. Selected reviews and practical experience are also taken into account, as are short messages selected by kaleidoscopy on general health policy and technical developments in the fields of dermatology, oncology, ophthalmology and pulmonology. The oncology campus offers a forum dedicated to the needs of advanced training assistants. [1]
2024
Mammakarzinom: Axilladissektion nicht immer nötig bei Sentinel-Metastasen
Kompass Onkologie , 2024 , pp 1-2.
Mammakarzinom: Der Nutzen einer verkürzten Therapiedauer mit Trastuzumab
Kompass Onkologie , 2024 , pp 1-2.
HER2-Status: Ein agnostischer Biomarker als Wegweiser für die T-DXd-Ansprechrate
Kompass Onkologie , 2024 , pp 1-2.
Progredienzangst: Online-Intervention für Brustkrebspatientinnen
Kompass Onkologie , 2024 , pp 1-2.
Mobile Health: Potenziale und Herausforderungen in der medizinischen Versorgung
No authors listed.
Kompass Onkologie , 2024 , pp 1-2.
B-Zell-mediierte Autoimmunerkrankungen: Risiko für B-Zell-Lymphome?
No authors listed.
Kompass Onkologie , 2024 , pp 1-2.